Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study
Milena Sant(Fondazione IRCCS Istituto Nazionale dei Tumori), Claire Schvartz(Fondazione IRCCS Istituto Nazionale dei Tumori), Magdalena Bielska‐Lasota(Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy), Karri Seppä, Ladislav Dušek(Institute of Health Information and Statistics), Roberto Agresti(Fondazione IRCCS Istituto Nazionale dei Tumori), Nadya Dimitrova(Istituto Superiore di Sanità), Margit Mägi(Universidad de Granada), Aurélien Belot, Guy Launoy(Inserm), Jean Faivre(Institut de Cancérologie de Lorraine), Mario Šekerija(London Cancer), Silvia Rossi(University of Parma), Gerda Engholm(National Board of Health and Welfare), Marc Maynadié(Universidad de Granada), Pamela Minicozzi(Fondazione IRCCS Istituto Nazionale dei Tumori), Florence Molinié, Bernd Holleczek(Krebsregister Saarland), Hans H. Storm(Danish Cancer Society), Brigitte Trétarre(Pancreatic Cancer Action Network), K. Henau, Anne‐Sophie Woronoff, Alexander Katalinic(Independent Centre for Privacy Protection), Michel Robaszkiewicz(Universidad de Granada), Nadine Bossard(Istituto Superiore di Sanità), Véronique Bouvier(Inserm), Sabine Siesling(Netherlands Comprehensive Cancer Organisation), Tiiu Aareleid(Fondazione IRCCS Istituto Nazionale dei Tumori), María Dolores Chirlaque López(Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública), Hilde Langseth(Cancer Registry of Norway), Marc Colonna(Universidad de Granada), Anne‐Marie Bouvier(Inserm), Z. Valerianova(Istituto Superiore di Sanità), Nerea Larrañaga(Basque Government), Nea Malila(Istituto Superiore di Sanità), Kaire Innos(National Institute for Health Development), Miroslav Zvolský(Institute of Health Information and Statistics), Willi Oberaigner, Alain Monnereau(Université Claude Bernard Lyon 1), X. Troussard, Monika Hackl(Universidad de Granada), P. Arveux(Istituto Superiore di Sanità), S. Bara(Fondazione IRCCS Istituto Nazionale dei Tumori), Michel Velten(Pancreatic Cancer Action Network), E. Van Eycken(Istituto Superiore di Sanità), Isabelle Baldi(Pancreatic Cancer Action Network), A.V. Guizard, N. Zielonke(Istituto Superiore di Sanità)
Cited by 279
Related Papers
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
|The Lancet Oncology|2019|1k
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
|JNCI Journal of the National Cancer Institute|2005|830
The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: Estimates of Radiation-Related Cancer Risks
|Radiation Research|2007|678
Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease
|JAMA|2003|659
The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers
|European Journal of Cancer|2021|650